Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States

• Asıl Yazarlar: John M. McLaughlin (Yazar), David L. Swerdlow (Yazar), Farid Khan (Yazar), Oliver Will (Yazar), Aaron Curry (Yazar), Vincenza Snow (Yazar), Raul E. Isturiz (Yazar), Luis Jodar (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Taylor & Francis Group, 2019-04-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: In September 2014, 13-valent pneumococcal conjugate vaccine (PCV13) was universally recommended for all US adults aged ≥65 years. Adult PCV13 coverage, including whether disparities in uptake exist, however, is not well-described. Methods: We used a monthly series of cross-sectional anal...